[Antitubercular properties of erythromycin A cyclic 11,12-carbonate in experiments in vitro and in vivo].
D000818:Animals; D000904:Antibiotics, Antitubercular; D004353:Drug Evaluation, Preclinical; D004352:Drug Resistance, Microbial; D004917:Erythromycin / Q000031:analogs & derivatives* / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D051379:Mice; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D014376:Tuberculosis / Q000382:microbiology
D000904:Antibiotics, Antitubercular; C029784:erythromycin A cyclic 11,12-carbonate; D004917:Erythromycin
Właściwości przeciwpratkowe cyklićznego 11,12-weglanu erytromycyny A w doświadczeniach in vitro i in vivo.